New‐onset diabetes after renal transplantation
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Renal transplantation has important benefits in people with end‐stage renal disease, with improvements in mortality, morbidity and quality of life. Whilst significant advances in transplantation techniques and immunosuppressive regimens have led to improvements in short‐term outcomes, longer‐term outcomes have not improved dramatically. New‐onset diabetes after transplantation appears to be a major factor in morbidity and cardiovascular mortality in renal transplant recipients. The diagnosis of new‐onset diabetes after renal transplantation has been hampered by a lack of clarity over diagnostic tests in early studies, although the use of the WHO criteria is now generally accepted. HbA 1c may be useful diagnostically, but should probably be avoided in the first 3 months after transplantation. The pathogenesis of new‐onset diabetes after renal transplantation is likely to be related to standard pathogenic factors in Type 2 diabetes (e.g. insulin resistance, β‐cell failure, inflammation and genetic factors) as well as other factors, such as hepatitis C infection, and could be exacerbated by the use of immunosuppression (glucocorticoids and calcineurin inhibitors). Pre‐transplant risk scores may help identify those people at risk of new‐onset diabetes after renal transplantation. There are no randomized trials of treatment of new‐onset diabetes after renal transplantation to determine whether intensive glucose control has an impact on cardiovascular or renal morbidity, therefore, treatment is guided by guidelines used in non‐transplant diabetes. Many areas of uncertainty in the pathogenesis, diagnosis and management of new‐onset diabetes after renal transplantation require further research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Woodle, E. S., First, M. R., Pirsch, J., Shihab, F., Gaber, A. O., & Van Veldhuisen, P. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e318187d1da · Cited by 474
Vanrenterghem, Y., Bresnahan, B., Campistol, J., Durrbach, A., Grinyó, J., Neumayer, H.-H., Lang, P., Larsen, C. P., Mancilla-Urrea, E., Pestana, J. M., et al. (2011) · Transplantation · doi:10.1097/tp.0b013e31820c10eb · Cited by 183
Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia
Sharif, A., Moore, R., & Baboolal, K. (2008) · Transplantation · doi:10.1097/tp.0b013e3181605ebf · Cited by 144
Werzowa, J., Hecking, M., Haidinger, M., Lechner, F., Döller, D., Pacini, G., Stemer, G., Pleiner, J., Frantal, S., & Säemann, M. D. (2013) · Transplantation · doi:10.1097/tp.0b013e318276a20e · Cited by 87
Oberholzer, J., Thielke, J., Hatipoglu, B., Testa, G., Sankary, H. N., & Benedetti, E. (2005) · Transplantation Proceedings · doi:10.1016/j.transproceed.2004.12.085 · Cited by 29
Cited by
A practical guide for the management of steroid induced hyperglycaemia in the hospital
Aberer, F., Hochfellner, D. A., Sourij, H., & Mader, J. K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102154 · Cited by 110
Obesity after kidney transplantation-results of a KTx360° substudy
Nöhre, M., Schieffer, E., Hanke, A., Pape, L., Schiffer, L., Schiffer, M., & de Zwaan, M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00399 · Cited by 27
Barchfeld, D. C., Vagi, R.-K., Lüdtke, K., Schieffer, E., Güler, F., Einecke, G., Jäger, B., de Zwaan, M., & Nöhre, M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1071705 · Cited by 10
“Additionally, an association between overweight and the development of new-onset diabetes after transplantation (NODAT) and hypertension has been described (12).”
BackgroundInfluential
Metadata
- Authors
- Tufton, N., Ahmad, S., Rolfe, C., Rajkariar, R., Byrne, C., & Chowdhury, T. A.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2014-10-15
- Volume
- 31
- Issue
- 11
- Pages
- 1284-1292
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2081814889
- Cited by
- 56
- References
- 5
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.